There is an increased incidence of the morbidity and mortality associated with fungal infections caused by resistant fungi in various groups of patients; therefore the monitoring of their susceptibility to antifungal agents to be necessary for optimizing clinical therapeutic treatment. The susceptibility profiles of recent clinical yeasts and yeast-like fungi isolated from Turin’s Hospitals to current antifungal drugs are here reported. Candida albicans was the most frequently isolated species (40%), followed by C. glabrata (22%).A high rate of susceptibility to all antifungal agents tested was observed and low evidence of resistance was found.
展开▼
